Cancer Treatment Reviews
Volume 31, Issue 4 , Pages 274-282 , June 2005

A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer

  • David Dodwell

      Affiliations

    • Cookridge Hospital, Leeds, Yorkshire LS16 6QB, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 (0) 1133 924 237; fax: +44 (0) 1133 924 052
    • ,
  • Ignace Vergote

      Affiliations

    • Department of Obstetrics and Gynaecology, University Hospital Leuven, Gasthuisberg, Herestraat 49, BE-3000 Leuven, Belgium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(05)00050-2

doi: 10.1016/j.ctrv.2005.03.009

Cancer Treatment Reviews
Volume 31, Issue 4 , Pages 274-282 , June 2005

Article Tools

* Image Usage & Resolution